Blog — Page 59

July 30, 2026

Cyber Liability Insurance Cost 2026: A Broker's Guide to First-Party vs Third-Party Coverage

A practical 2026 guide to cyber liability insurance for U.S. small and mid-sized businesses. From a commercial broker's chair: first-party coverage (ransomware, business interruption, data restoration, cyber extortion, forensics, notification) versus third-party coverage (data breach liability, regulatory fines, legal defense), how MFA, EDR and backups drive underwriting and price, sublimits, cost factors, industry ranges, the claims process, and the mistakes buyers keep making.

cyber insurance cyber liability ransomware

July 30, 2026

Individual Disability Income Insurance Cost Guide 2026: Own-Occupation, Riders, and What You Actually Pay

A 2026 plain-English guide to individual disability income (IDI) insurance in the US. Learn own-occupation vs any-occupation, elimination and benefit periods, key riders like COLA and residual, how premiums are priced by age and occupation class, plus group vs individual coverage and taxation, from an independent advisor's perspective.

disability insurance income protection own occupation

July 30, 2026

Elevator and Escalator Accident Lawsuits 2026: Who Is Liable and How to Win

A practical 2026 guide to elevator and escalator injury lawsuits in the US: how liability splits among the property owner, the maintenance contractor (Otis, KONE, Schindler, TK Elevator) and the manufacturer, plus premises versus product liability, res ipsa loquitur, evidence preservation, settlement, statutes of limitation and contingency fees.

elevator accident escalator accident personal injury

July 30, 2026

Dram Shop Liability Lawsuit Guide 2026: When a Bar Pays for a Drunk Driver's Crash

A plaintiff-side attorney's practical read on dram shop liability: when a bar, restaurant, or liquor store that over-served a visibly intoxicated or underage patron can be held responsible for the third-party injuries that patron causes. State-by-state law, visible intoxication, foreseeability, damages, liquor liability insurance, proof, and how contingency fees work.

Dram Shop Liquor Liability DUI Lawsuit

July 30, 2026

BAH (Booz Allen Hamilton) Stock Outlook 2026: The Government Trust Moat Versus Budget-Cut Risk

BAH (Booz Allen Hamilton) 2026 stock outlook. A qualitative deep dive into its AI, cyber, and digital consulting for U.S. defense and intelligence agencies, the cleared-workforce and backlog moat, the VoLT strategy, budget and efficiency (DOGE) risk, and single-customer concentration.

BAH Booz Allen Hamilton US Stocks

July 30, 2026

Sterling Infrastructure (STRL) Stock Outlook 2026: The Data Center Site-Work Boom and a Rerating in Progress

Sterling Infrastructure (STRL) 2026 stock outlook. A qualitative deep dive into the high-growth E-Infrastructure segment building data center and chip-fab sites, the margin mix shift, cyclical exposure in Transportation and Building, and the customer-concentration and acquisition-integration risks that balance the bull case.

STRL Sterling Infrastructure data centers

July 30, 2026

Franklin Resources (BEN) Stock Outlook 2026: Active Outflows vs the Alternatives Pivot

A 2026 stock outlook for Franklin Resources (Franklin Templeton, NYSE: BEN). We dig into the scale-and-distribution moat, the push into private credit, secondaries and real estate, the high dividend, and the structural risks of active outflows, fee compression and the Western Asset shock.

BEN Franklin Resources Franklin Templeton

July 30, 2026

Morningstar (MORN) Stock Outlook 2026: The Subscription Moat vs. the Capital-Markets Cycle

Morningstar (MORN) stock outlook for 2026. A qualitative deep dive into recurring subscription revenue and brand trust, PitchBook's structural growth in private-market data, DBRS credit-rating issuance sensitivity, competition from FactSet, Bloomberg, S&P Global, and MSCI, and exposure to the asset-management cycle.

MORN Morningstar US Stocks

July 30, 2026

JAZZ (Jazz Pharmaceuticals) Stock Outlook 2026: The Oxybate Franchise vs. the Patent Cliff

Jazz Pharmaceuticals (NASDAQ: JAZZ) 2026 stock outlook. A qualitative deep dive into the Xywav low-sodium conversion strategy, Epidiolex epilepsy growth, the Rylaze and Zepzelca oncology mix, the oxybate patent cliff, Avadel's Lumryz threat, and acquisition-driven growth with leverage risk.

JAZZ Jazz Pharmaceuticals US Stocks

July 30, 2026

MEDP (Medpace) Stock Outlook 2026: An Owner-Run CRO's Margin Moat Meets the Biotech Funding Cycle

MEDP (Medpace Holdings) 2026 stock outlook. A qualitative deep dive into the founder-led, single-integrated full-service CRO built for small and mid-cap biotech, its high margins and book-to-bill engine, and why net new business awards and backlog swing with the biotech funding cycle, benchmarked against IQVIA, ICON, and Charles River.

MEDP Medpace CRO

July 30, 2026

Group 1 Automotive (GPI) Stock Outlook 2026: The Dealer Roll-Up and the Real Value of Service Annuities

Group 1 Automotive (GPI) 2026 stock outlook. A deep look at the high-margin Parts and Service annuity, F&I economics, new and used vehicle GPU normalization, UK expansion, dealer M&A roll-up, the EV service debate, and how GPI stacks up against AutoNation, Penske, Lithia and Asbury for long-term investors.

GPI Group 1 Automotive US Stocks

July 30, 2026

WCC (Wesco International) Stock Outlook 2026: Distribution Moat Meets Cyclical Reality

WCC (Wesco International) 2026 stock outlook. A deep qualitative look at the EES, CSS, and UBS segments, the Anixter integration, data center and grid electrification and reshoring demand, and the distribution scale and switching-cost moat versus cyclicality, thin margins, and debt and rate risk.

WCC Wesco International US Stocks

July 30, 2026

Owens Corning (OC) Stock Outlook 2026: Re-Roofing Demand Meets a Portfolio Reset

Owens Corning (OC) 2026 stock analysis: the recurring re-roofing demand behind asphalt shingles, the energy-efficiency structural growth in fiberglass insulation, the new Doors segment from the 2024 Masonite acquisition, the composites divestiture that sharpens a high-margin building-products profile, strong free cash flow with buybacks and a dividend, and the US housing new-build and remodel cycle risk that still hangs over the story.

OC Owens Corning US Stocks

July 30, 2026

NVR Stock Outlook 2026: The Asset-Light Homebuilder Compounder and Its Real Risks

NVR Inc (NYSE: NVR) 2026 stock outlook. A qualitative deep dive into the lot-option asset-light land model, Ryan Homes brand strength, NVR Mortgage vertical integration, the no-dividend buyback compounding engine, and the rate, affordability, and ultra-high-share-price risks investors need to weigh.

NVR US Stocks Homebuilders

July 30, 2026

Taewoong (044490) Stock Outlook 2026: Free-Forging Moat Meets the Wind and SMR Growth Story

Taewoong 044490 stock outlook 2026 for international investors: a Korean free-forging specialist supplying wind tower flanges and main shafts, an early SMR forged-component contract for a 300MW Canadian reactor, plus the order volatility, steel-plate cost, and CAPEX-cycle risks that define this KOSDAQ name.

Taewoong 044490 Korea stocks

July 30, 2026

Songwon Industrial (004430) Stock Outlook 2026: The World's No. 2 Antioxidant Maker and Its Spread Dilemma

Songwon Industrial (KOSPI 004430) 2026 stock outlook. A deep qualitative look at the global No. 2 polymer antioxidant oligopoly, tin and PVC stabilizers plus specialty chemicals, certification-based switching costs, phenol feedstock spread swings, cyclical thin margins, the comparison with BASF, and a Korea-stock cyclical value lens.

Songwon 004430 Korea Stocks

July 30, 2026

Cosmo Chemical (005420) Stock Outlook 2026: A TiO2 Monopoly, a Loss Cycle, and a Battery Recycling Option

A 2026 stock outlook for Cosmo Chemical (KOSPI 005420), Korea's only titanium dioxide (TiO2) producer. We weigh its domestic monopoly cash cow against a Chinese-driven price war and loss cycle, plus the battery-materials and spent-battery recycling growth option tied to affiliate Cosmo Advanced Materials.

Cosmo Chemical 005420 titanium dioxide

July 30, 2026

Gravity (GRVY / 117730) Stock Outlook 2026: The Ragnarok Single-IP Long Tail and New-Title Risk

Gravity Co. (NASDAQ: GRVY / KOSDAQ: 117730) 2026 stock analysis for global investors: the Ragnarok Online single-IP global long tail across Southeast Asia, Taiwan, and Japan in 91 countries, the mobile-remake-licensing revenue engine, the console Ragnarok project targeting 2027, and the single-IP dependence, hit-driven volatility, small-cap liquidity, and dual-listing dynamics that define this game publisher.

Gravity GRVY Ragnarok

July 30, 2026

Manyo Factory (439090) Stock Outlook 2026: K-Beauty Indie Export Growth vs. Single-Hero-Product Risk

Manyo Factory (KOSDAQ 439090) 2026 stock outlook. A qualitative deep dive into its vegan clean-beauty brand equity and Pure Cleansing Oil hero product, Japan, US and Southeast Asia export channels, asset-light ODM model, reliance on distributors like Silicon2, and marketing-spend and beauty-trend risks for global investors.

Manyo Factory 439090 K-beauty

July 30, 2026

Wontech (336570) Stock Outlook 2026: Oligio Tip Consumables, Razor-Blade Revenue, and the Aesthetic Spending Cycle

A qualitative 2026 outlook on Wontech (KOSDAQ 336570), the Korean energy-based aesthetic device maker behind Oligio monopolar RF and Picocare picosecond lasers. We dissect the razor-blade model of device sales plus recurring tip and cartridge consumables, export expansion across Asia, Europe, the Middle East and Latin America, rivalry with Classys, Jeisys Medical and Lutronic, and the discretionary aesthetic spending risk for Korea-focused investors.

Wontech 336570 Oligio

July 30, 2026

i-SENS (099190) Stock Outlook 2026: A BGM Cash Cow Funding a CGM Growth Option

i-SENS (099190) 2026 stock outlook. A deep qualitative look at the self-monitoring blood glucose (BGM) cash cow, the continuous glucose monitor (CGM) localization and reimbursement growth option, the electrochemical biosensor platform, overseas OEM supply, competition from Abbott Libre and Dexcom, CGM investment losses, and currency risk.

i-SENS 099190 Korea Stocks

July 30, 2026

Korea Electric Terminal (KET, 025540) Stock Outlook 2026: The Quiet Connector Play on Car Electrification

Korea Electric Terminal (KET, KOSPI 025540) 2026 stock outlook. A deep, qualitative look at rising connector content per vehicle from automotive electrification, EV high-voltage and high-speed data connectors, ADAS growth, and the offsetting risks of Hyundai-Kia customer concentration, a low-PBR discount, and global rivals like TE Connectivity, Aptiv, Molex and Yazaki.

Korea Electric Terminal KET 025540

July 30, 2026

LX Hausys (KRX 108670) Stock Outlook 2026: Where the Remodeling Cycle Meets the Resin Spread

LX Hausys (KRX 108670) 2026 stock outlook. A qualitative deep dive into its building-materials portfolio (PF insulation, PVC and aluminum windows, flooring, decorative film, HIMACS solid surface) plus auto materials and industrial film, its leverage to Korea's housing transaction and remodeling cycle, PVC and crude-oil spread margin sensitivity, and the tension between structural B2B premium growth and a soft domestic construction market.

LX Hausys 108670 Korea Stocks

July 30, 2026

TES (KOSDAQ 095610) Stock Outlook 2026: A Leveraged Bet on Samsung and SK Hynix CAPEX

TES (KOSDAQ 095610) 2026 stock outlook. A deep, qualitative look at its PECVD deposition and gas-phase etch and cleaning equipment, exposure to Samsung and SK Hynix CAPEX cycles, HBM and leading-edge tailwinds, customer concentration, equipment-stock volatility, and Chinese competition.

TES 095610 semiconductor equipment